Pharmaceutical

Solve FSHD to invest in Armatus Bio for ARM-201 development

Venture philanthropy organisation Solve FSHD has announced an investment of $3m in Armatus Bio to support the development of ARM-201.

May 8, 2025 - 06:00
Solve FSHD to invest in Armatus Bio for ARM-201 development
Venture philanthropy organisation Solve FSHD has announced an investment of $3m in Armatus Bio to support the development of ARM-201.
Read the original article

Tags:

Previous Article

Sarepta shares fall amid FDA’s CBER appointment and weak Elevidys sales

Next Article

Expediting parallel drug approval pathways is challenging, but rewarding

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Health care industry fights back against crackdowns on health data tracking

STAT+: Health care industry fights back against crackdo...

Dec 19, 2023

iTeos and GSK hit enrolment milestone with Phase III TIGIT lung cancer trial 

iTeos and GSK hit enrolment milestone with Phase III TI...

Jul 10, 2024

Bayer applies for EU approval of menopause drug elinzanetant

Bayer applies for EU approval of menopause drug elinzan...

Oct 16, 2024